Pilot study indicates that Tinearity G1 is an effective tool to combat tinnitus
A pilot study, conducted by Leonel Luis, professor in otology shows that Tinearity G1 has significant impact on tinnitus suffers.
The study involved 30 individuals who used Tinearity G1 for one month. 70% experienced an improvement of their TFI score. In addition all of individuals who’s tinnitus tone is below 4kHz experienced an improvement of their TFI score.
-”We’re very pleased with the result and this is a great platform for further clinical trials to improve our understanding to tinnitus and how Tinearity G1 can help tinnitus suffers” says Fredrik Westerberg, CEO of Duearity.
The study was conducted by Leonel Luis, professor in otology at Santa Maria Hospital in Lisbon, Portugal. The study and results will be presented at the Otoneurology PT Society between the 13-14th of October and at the International Otology Disorders Academy Congress 1-4th of November.
Duearity is a medical device company that develops solutions for minimizing tinnitus. Their first device – Tinearity G1 – is CE certified and has a 510(k) FDA clearance. Duearity is listed on Nasdaq First North and has its headquarters in Malmö, Sweden.